SCHEMBL4733929

SCHEMBL4733929

Cc1cc2c(cc1S(=O)(=O)NCCC#N)S(=O)(=O)c1ccccc1CC2

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PARG Q86W56 1/20 0.39
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
ALOX5AP P20292 2/20 0.35
FEN1 P39748 2/20 0.35
TDP1 Q9NUW8 1/20 0.34
LMNA P02545 3/20 0.33
CYP2C9 P11712 1/20 0.33
SFRP1 Q8N474 1/20 0.33
KMT2A Q03164 3/20 0.32
MEN1 O00255 2/20 0.32
MAOA P21397 1/20 0.32
TP53 P04637 2/20 0.31
HTT P42858 1/20 0.31
POLB P06746 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4733822 0.84 SFRP1 (0.50) TDP1SFRP1KMT2AMEN1HTT
SCHEMBL4732336 0.81 AKR1C3 (0.41) PDE4BPDE4CPDE4DTDP1LMNA
SCHEMBL4732136 0.81 MEN1 (0.47) TDP1LMNASFRP1KMT2AMEN1
SCHEMBL4733373 0.79 BRD4 (0.40) TDP1LMNACYP2C9KMT2AMEN1
SCHEMBL4729711 0.79 ALDH1A1 (0.52) CYP2C9KMT2AMEN1
SCHEMBL4733942 0.78 POLB (0.48) TDP1SFRP1HTTPOLB
SCHEMBL4785987 0.78 PARG (0.38) PARGPDE4APDE4BPDE4CPDE4D
SCHEMBL4731794 0.77 CYP3A4 (0.49) TDP1KMT2APOLB
SCHEMBL4734831 0.77 PARG (0.36) PARGPDE4APDE4BPDE4CPDE4D
SCHEMBL4733897 0.76 CNR2 (0.40) TP53HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008061029-A1 ARYL SULFONAMIDE DERIVATIVES AND METHODS OF THEIR USE WYETH (US) 2008-05-22 WO claimed
WO-2008061029-A1 ARYL SULFONAMIDE DERIVATIVES AND METHODS OF THEIR USE WYETH (US) 2008-05-22 WO disclosed